https://www.businesswire.com/news/home/20220623005585/en/Novaremed-Announces-Publication-of-Phase-1-and-Phase-2a-Study-Data-With-NRD.E1-Demonstrating-the-Potential-of-This-Investigational-Non-opioid-Pain-Treatment
Novaremed Announces Publication of Phase 1 and Phase 2a Study Data With NRD.E1 Demonstrating the...
Novaremed AG, a privately held clinical-stage biopharmaceutical company focused on innovative non-opioid treatment options for chronic pain management announ...
https://www.novaremed.com/index.html
Home | Novaremed